de Leeuw P - Search Results

1

Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Persu A, Dobrowolski P, Gornik HL, Olin JW, Adlam D, Azizi M, Boutouyrie P, Bruno RM, Boulanger M, Demoulin JB, Ganesh SK, J Guzik T, Januszewicz M, Kovacic JC, Kruk M, de Leeuw P, Loeys BL, Pappaccogli M, Perik MHAM, Touzé E, Van der Niepen P, Van Twist DJL, Warchoł-Celińska E, Prejbisz A, Januszewicz A. Persu A, et al. Among authors: de leeuw p. Cardiovasc Res. 2022 Jan 7;118(1):65-83. doi: 10.1093/cvr/cvab086. Cardiovasc Res. 2022. PMID: 33739371 Free PMC article. Review.

2

Blood pressure and renal function before and after percutaneous transluminal renal angioplasty in fibromuscular dysplasia: a cohort study.

Smit JV, Wierema TK, Kroon AA, de Leeuw PW. Smit JV, et al. J Hypertens. 2013 Jun;31(6):1183-8. doi: 10.1097/HJH.0b013e32836044b2. J Hypertens. 2013. PMID: 23588195

3

Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.

van Twist DJ, Houben AJ, de Haan MW, Mostard GJ, Kroon AA, de Leeuw PW. van Twist DJ, et al. Hypertension. 2013 Oct;62(4):789-93. doi: 10.1161/HYPERTENSIONAHA.113.01814. Epub 2013 Aug 5. Hypertension. 2013. PMID: 23918750 Clinical Trial.

4

European consensus on the diagnosis and management of fibromuscular dysplasia.

Persu A, Giavarini A, Touzé E, Januszewicz A, Sapoval M, Azizi M, Barral X, Jeunemaitre X, Morganti A, Plouin PF, de Leeuw P; ESH Working Group Hypertension and the Kidney. Persu A, et al. Among authors: de leeuw p. J Hypertens. 2014 Jul;32(7):1367-78. doi: 10.1097/HJH.0000000000000213. J Hypertens. 2014. PMID: 24842696 Review.

5

Angiotensin-(1-7) as a strategy in the treatment of hypertension?

van Twist DJ, Kroon AA, de Leeuw PW. van Twist DJ, et al. Curr Opin Nephrol Hypertens. 2014 Sep;23(5):480-6. doi: 10.1097/MNH.0000000000000050. Curr Opin Nephrol Hypertens. 2014. PMID: 25023950 Review.

6

Reply: diagnosis and management of fibromuscular dysplasia.

Persu A, Januszewicz A, Morganti A, Plouin PF, de Leeuw P. Persu A, et al. Among authors: de leeuw p. J Hypertens. 2014 Oct;32(10):2098-9. doi: 10.1097/HJH.0000000000000315. J Hypertens. 2014. PMID: 25186531 No abstract available.

7

Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis.

Van Twist DJ, Houben AJ, De Haan MW, Mostard GJ, De Leeuw PW, Kroon AA. Van Twist DJ, et al. J Hypertens. 2014 Dec;32(12):2428-32; discussion 2432. doi: 10.1097/HJH.0000000000000351. J Hypertens. 2014. PMID: 25208127

8

Renal hemodynamics and renin-angiotensin system activity in humans with multifocal renal artery fibromuscular dysplasia.

van Twist DJ, Houben AJ, de Haan MW, de Leeuw PW, Kroon AA. van Twist DJ, et al. J Hypertens. 2016 Jun;34(6):1160-9. doi: 10.1097/HJH.0000000000000917. J Hypertens. 2016. PMID: 27032075

9

Acute eprosartan-induced intrarenal vasodilation in hypertensive humans is not influenced by dietary sodium intake or angiotensin II co-infusion.

van Twist DJ, Houben AJ, de Leeuw PW, Kroon AA. van Twist DJ, et al. J Hypertens. 2016 Aug;34(8):1607-14. doi: 10.1097/HJH.0000000000000974. J Hypertens. 2016. PMID: 27214088

10

Pathophysiological differences between multifocal fibromuscular dysplasia and atherosclerotic renal artery stenosis.

van Twist DJ, Houben AJ, de Haan MW, de Leeuw PW, Kroon AA. van Twist DJ, et al. J Hypertens. 2017 Apr;35(4):845-852. doi: 10.1097/HJH.0000000000001243. J Hypertens. 2017. PMID: 28060190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

709 results

Search Page